Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02901301 |
|---|---|
| Brief Title: | Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer |
| First Submitted : | September 11, 2016 |
| First Submitted that Met QC Criteria : | September 14, 2016 |
| First Posted : | September 15, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 1, 2021 |
| Last Update Posted : | April 6, 2021 |